[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1959

Corticotropin (ACTH) and Adrenal Steroids in Liver DiseaseA Critical Review

Author Affiliations

Chicago

Department of Medicine, The University of Chicago.

AMA Arch Intern Med. 1959;104(3):469-489. doi:10.1001/archinte.1959.00270090123018
Abstract

Introduction  Corticotropin (ACTH) and adrenal steroids in recent years have gained a prominent place in the therapeutic armamentarium of human disease. While their biologic and pharmacological actions have been studied extensively, these compounds often are prescribed, without apparently sound scientific basis, because of the absence of more effective measures, in severe life-threatening diseases. In the course of other studies, it appeared useful to review the readily available medical literature and to evaluate the usefulness and the limitations of these drugs in hepatic disease.Corticotropin and adrenal steroids have variable physiological and pharmacological effects in different species of animals. According to Long,1 mice, rats, and rabbits are cortisone-sensitive, while guinea pigs, monkeys, and men are cortisone-resistant. The effects of these substances also vary according to the dosage. A "moderate" therapeutic dose of adrenal steroids may exercise beneficial physiological effects, while large doses may be harmful. Basically, steroids are anabolic,2

First Page Preview View Large
First page PDF preview
First page PDF preview
×